Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review
Forlagets udgivne version
Obese subjects are often characterized by low plasma 25-hydroxy-vitamin D (25OHD) levels. Many explanations for this association have been proposed. Low plasma 25OHD is associated with obesity-related comorbidities such as insulin resistance, type 2 diabetes mellitus, and low-grade inflammation. In this review, we discuss the proposed mechanisms for low 25OHD in obesity and explore the results of recent RCTs on vitamin D (VD) supplementation on obesity and its metabolic complications such as insulin resistance and type 2 diabetes. Although the results from these clinical randomized controlled trials vary, the general picture is that VD treatment of obese individuals does not seem to be an effective treatment of obesity-related metabolic complications.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 4 |
Tidsskrift | Current obesity reports |
Vol/bind | 4 |
Nummer | 4 |
Sider (fra-til) | 429-40 |
Antal sider | 12 |
DOI | |
Status | Udgivet - 4 dec. 2015 |
Se relationer på Aarhus Universitet Citationsformater
ID: 93690853